CAV2.3 expression is upregulated in the substantia nigra pars compacta of humans with Parkinson's disease
Parnaz Sharifi,
Haesoo Bae,
Djordje Gveric,
Steve M Gentleman,
Peter JS Smith,
Travis S Tierney,
Kambiz N. Alavian
Affiliations
Parnaz Sharifi
Department of Brain Sciences, Burlington Danes Hammersmith Hospital, Imperial College London, DuCane Road, London W12 0NN, UK
Haesoo Bae
Department of Brain Sciences, Burlington Danes Hammersmith Hospital, Imperial College London, DuCane Road, London W12 0NN, UK
Djordje Gveric
Department of Brain Sciences, Burlington Danes Hammersmith Hospital, Imperial College London, DuCane Road, London W12 0NN, UK; Parkinson's Tissue Bank, Imperial College London, London, UK
Steve M Gentleman
Department of Brain Sciences, Burlington Danes Hammersmith Hospital, Imperial College London, DuCane Road, London W12 0NN, UK; Parkinson's Tissue Bank, Imperial College London, London, UK
Peter JS Smith
Institute for Life Sciences, University of Southampton, Southampton, UK
Travis S Tierney
Department of Brain Sciences, Burlington Danes Hammersmith Hospital, Imperial College London, DuCane Road, London W12 0NN, UK
Kambiz N. Alavian
Department of Brain Sciences, Burlington Danes Hammersmith Hospital, Imperial College London, DuCane Road, London W12 0NN, UK; Institute for Life Sciences, University of Southampton, Southampton, UK; Department of Internal Medicine, Endocrinology, Yale University, New Haven, CT, USA; Corresponding author at: Department of Brain Sciences, Burlington Danes Hammersmith Hospital, Imperial College London, DuCane Road, London W12 0NN, UK.
